About Veeva Systems Inc. Class A Common Stock (VEEV)
Veeva Systems Inc is a leading provider of cloud-based software solutions tailored specifically for the global life sciences industry. The company offers a range of products designed to streamline and enhance various aspects of the pharmaceutical and biotech sectors, including research and development, regulatory compliance, and commercial operations. By leveraging advanced technology and data analytics, Veeva enables life sciences organizations to improve their efficiency, accelerate drug development processes, and ensure adherence to regulatory standards, ultimately contributing to better patient outcomes and innovation in healthcare. Read More
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
A number of stocks fell in the afternoon session after a broad sell-off in the software sector was triggered by mixed earnings from industry leaders SAP and ServiceNow.
Software is rapidly reducing operating expenses for businesses. In the past, the undeniable tailwinds fueling SaaS companies led to lofty valuation multiples that made it easier to raise capital.
But this was a double-edged sword as the high prices exposed them to big drawdowns, and unfortunately, the industry has tumbled by 11.2% over the last six months. This drawdown is a far cry from the S&P 500’s 10% ascent.
Growth is oxygen.
But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
A number of stocks fell in the afternoon session after tech stocks pulled back as reports surfaced that Chinese customs authorities blocked Nvidia's H200 AI chips, effectively halting their entry despite recent U.S. export approvals.
The digital health landscape faced a sobering milestone this week as shares of Doximity, Inc. (NYSE: DOCS), the leading professional network for physicians, plummeted to a new 52-week low. On January 12, 2026, the stock touched $43.21, marking a dramatic retreat from its February 2025 peak of $85.21.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at vertical software stocks, starting with Veeva Systems (NYSE:VEEV).
Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) jumped 6.6% in the afternoon session after the company's Board of Directors approved a share repurchase program, authorizing the purchase of up to $2 billion of its stock.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Quantum Capital Management, LLC / NJ disclosed a sale of 61,397 shares of Landstar System as of its November 12, 2025, SEC filing, reducing the position by an estimated $12.83 million.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
New York, NY – December 16, 2025 – UiPath (NYSE: PATH), a leader in enterprise automation software, has recently captivated financial markets with a significant surge in its stock price, largely attributed to its strategic advancements in artificial intelligence partnerships and consistent Annual Recurring Revenue (ARR) growth. After a remarkable rally that
Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) fell 3% in the morning session after a lack of positive news catalysts allowed technical trading patterns to dominate, continuing its recent underperformance. According to technical analysis, the stock's recent price behavior had been difficult. Its technical rating was poor, with negative trends observed in both the short and long term. The stock also underperformed the wider S&P 500 index over recent months. This downward move was followed by a consolidation period, a pattern that some traders viewed as a potential signal for further declines.
Combine fundamental and technical analysis for smarter investing. See how Veeva Systems exemplifies this strategy with strong growth metrics and a potential chart breakout.
Veeva Systems exemplifies GARP investing with strong profitability, debt-free stability, solid growth, and a reasonable valuation in the life sciences software sector.
Free cash flow is one of the most reliable indicators of financial durability.
These businesses not only generate cash but reinvest intelligently to sustain momentum.
Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) fell 10.6% in the afternoon session after the company reported third-quarter results that beat Wall Street's expectations, but the market seemingly hoped for more, focusing on a potential slowdown in future growth.
